Treatment of acute promyelocytic leukemia: A single institution experience. Tratamiento de la leucemia promielocítica aguda. Experiencia de una sola institución. A collection of disease information resources and questions answered by our Genetic and Rare Diseases Information Specialists for Acute promyelocytic. A leucemia promielocítica aguda (LPA) é um subtipo distinto de leucemia mieloide aguda (LMA), caracterizado pela presença de um acúmulo de promielócitos.
|Published (Last):||15 August 2017|
|PDF File Size:||3.26 Mb|
|ePub File Size:||4.65 Mb|
|Price:||Free* [*Free Regsitration Required]|
Blood ; 90 Suppl. Treatment of newly diagnosed acute promyelocytic leukemia APL: The impact of medical education and networking on the outcome of leukemia treatment in developing countries.
leuccemia Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia: Chromatin modulation by oncogenic transcription factors: Substantial progress has occurred promelocitica the treatment of APL because of improved understanding of the pathophysiology of the disease and identification of a molecular target.
Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. ATRA was given until reaching a complete hematological remission, as defined by usual criteria.
The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation.
The according with results, the patients were classified following: A maior causa de morte foi a hemorragia grave, especialmente no sistema nervoso central SNC.
Only comments written in English can be processed. Results from several randomized studies have evaluated various regimens of ATRA alone or in combination with CT to determine optimal induction therapy in patients with newly diagnosed APL.
Flow cytometry in the clinical laboratory. Oral prednisone is used prophylactically, ATRA is given on an outpatient basis and adriamycin is used instead of other anthracyclines.
Who Classification of tumours of haematopoietic and lymphoid tissues. Other search option s Alphabetical list. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.
Superiority of an arsenic trioxide-based regimen over a historic control combining all-trans retinoic acid plus intensive chemotherapy in the treatment of relapsed lwucemia promyelocytic leukemia. Reduced activity of TAFI thrombin-activable fibrinolysis inibitor in acute promyelocytic leukemia.
Trombose arterial em leucemia promielocítica aguda
Trisomy 21 and other chromosomal abnormalities in acute promyelocytic leukemia. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: A new variant t 6;15;17 q25;q22;q21 in acute promyelocytic leukemia: Disease definition Acute promyelocytic leukemia APL promielociticz an aggressive form of acute myeloid leukemia AML; see this termcharacterized by arrest of leukocyte differentiation at the promyelocyte stage, due to a specific chromosomal translocation t 15;17 in myeloid cells.
Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Toxicity and response criteria of the Eastern Cooperative Oncology Group.
Advances in the understanding and management of acute promyelocytic leukemia. Differentiation therapy of acute promyelocytic leukemia with tretinoin all-trans-retinoic acid.
Mediterr J Primielocitica Infect Dis.
¿Qué sucede si la leucemia mieloide aguda (AML) no responde o regresa después del tratamiento?
Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Promyelocytic leukemia in Mexican mestizos. Loss of the tumor suppressor PML in human prpmielocitica of multiple histologic origins. Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.
Fourteen patients were followed for more than 30 days and therefore, prospectively accrued in this study; they were observed for periods ranging from 67 to 4, days median 1, In addition, we elected to deliver ATRA fully on an outpatient basis, thus primielocitica hospitalization costs. Presenting white blood cell lsucemia and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Haemostatic problems in Acute Leukaemia.
Benzene as a model.
Orphanet: Leucemia promielocitica acuta
Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia. Am J Hematol ; Surveillance for any hemorrhagic signs is necessary, due to the high risk of disseminated intravascular coagulation. Abnormalities in hemostasis in acute promyelocytic leukemia.